Intravenous (IV) Iron Drugs Market 2020 Size, Share, Regional Growth, Industry Outlook and Forecast till 2026

Rising demand for preventive care is a key factor driving the global "intravenous (IV) iron drugs" market, says Fortune Business Insights in a report, titled "Intravenous (IV) Iron Drugs Market Size, Share and Global Trend By Type (Iron Sucrose, Dextran, Ferric Carboxyl Maltose, Ferric Gluconate), By Application (Gynecology, Oncology, Nephrology), By End User (Hospitals, Ambulatory Surgery Centers, Homecare Settings) and Geography Forecast till 2026." Increasing R&D investments in intravenous iron by key players is expected to aid the growth of the global intravenous (IV) iron drugs market.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/intravenous-iv-iron-drugs-market-101236

According to the report, the rising prevalence of anemia is predicted to contribute positively to the global intravenous (IV) iron drugs market revenue. symptoms of anemia include loss of energy and fatigue, difficulty in concentration, pale skin and dizziness, insomnia and cramps. According to a survey conducted by the Vitamin and Mineral Nutrition Information System. In 2017, approximately 30% of women and children in developing countries suffered from anemia.

Highlights of the Intravenous (IV) Iron Drugs Market Report Include:

o Microscopic study of the various factors driving and restraining the market
o Careful classification and research of the market segments
o Accurate computation of market figures
o Comprehensive analysis of the regional dynamics and competitive landscape

Key Players Operating in The Intravenous (IV) Iron Drugs Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Daiichi Sankyo, Inc.
o Sanofi
o AMAG Pharmaceuticals, Inc
o Allergan
o Nippon Shinyaku Co., Lt
o Pharmacosmos A/S.
o And others.

North America dominated the intravenous (IV) iron drugs market in 2018 due to the increasing prevalence of anemia and rising cases of associated diseases such as celiac disease along with inflammatory bowel disease. Moreover, high healthcare expenditure, access to advanced intravenous (IV) iron drugs and rising demand for preventive medical care will further favor growth in North America. Asia Pacific is predicted grow at a remarkable rate during the forecast period owing to the increasing awareness and cases of anemia and growing access to intravenous (IV) iron drugs. The rising prevalence of acute and severe diseases such as inflammatory bowel disease will also accelerate growth in North America. Latin America and the Middle East and Africa are expected to grow at a relatively lower CAGR during the forecast period.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/intravenous-iv-iron-drugs-market-101236

FDA Approval for I.V. TRIFERIC? Will Enable Growth
Rockwell Medical, Inc. a biopharmaceutical and therapeutic company based in Wixom, Michigan launched a New Drug Application (NDA) for its Intravenous (I.V.) formulation of TRIFERIC? with a PDUFA (Prescription Drug User Fee Act) after receiving approval from the Food and Drug Administration (FDA). Dialysate Triferic is mixed with liquid bicarbonate to deliver iron to patients via the dialysate, while I.V. Triferic is designed for intravenous administration to patients. The launch of I.V. TRIFERIC? by Rockwell Medical, Inc. will boost the global intravenous (IV) iron drugs market revenue during the forecast period.

Intravenous (IV) Iron Drugs Market Segmentation:

By Type
o Iron Sucrose
o Dextran
o Ferric Carboxyl Maltose
o Ferric Gluconate
o Others
By Application
o Gynecology
o Oncology
o Nephrology
o Others
By End User
o Hospitals
o Ambulatory Surgery Centers
o Homecare Settings
o Others
By Geography
o North America (USA and Canada)
o Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
o Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
o Latin America (Brazil, Mexico and Rest of Latin America)
o Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Order Full Report: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/intravenous-iv-iron-drugs-market-101236

Related Reports:

DNA Sequencing Market 2020: Global Size, Top Key Companies, Industry Analysis by Trends, Future Growth and Regional Forecasts Research Report 2026- https://www.marketwatch.com/press-release/dna-sequencing-market-2020-global-size-top-key-companies-industry-analysis-by-trends-future-growth-and-regional-forecasts-research-report-2026-2020-02-11

Parkinson's Disease Drugs Market by Top Key Players are Pfizer, Roche, Merck, Novartis, Orion Pharma,UCB and more Forecast by 2026- https://www.marketwatch.com/press-release/parkinsons-disease-drugs-market-by-top-key-players-are-pfizer-roche-merck-novartis-orion-pharmaucb-and-more-forecast-by-2026-2019-12-06

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

This release was published on openPR.